About 5,510,000 results
Open links in new tab
In sustained rare disease push, Recordati lays out $825M upfront …
Sanofi Sells Global Rights To Rare Autoimmune Drug Enjaymo For …
RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO ...
Recordati to Buy Global Rights to Sanofi's Enjaymo for $825 Million
RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO ...
Sanofi’s rare disease drug finds yet another home
Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential …
Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo
Recordati buys rights to rare immune disorder drug from Sanofi …
- Some results have been removed